Clinical Trial Update: Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 study evaluating NaBen as an add-on treatment for schizophrenia in adults has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• NaBen

Snippet

Sponsor: SyneuRx International (Taiwan) Corp | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: TERMINATED